However, the strong correlation between the PRRX1 signature and expression of immune checkpoint molecules is in striking accordance with the findings of a recent study of patients with metastatic gastric adenocarcinoma where the mesenchymal-like tumor subgroup had high expression of HAVCR2/TIM-3 and VISTA (29). This evidence concerns the gene PRRX1 and neoplasm.